<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Orzecznictwo w zakresie prawa IP i prawa IT &#187; Dodatkowe świadectwo ochronne</title>
	<atom:link href="http://orzecznictwo.net/category/prawo/dodatkowe-swiadectwo-ochronne/feed/" rel="self" type="application/rss+xml" />
	<link>http://orzecznictwo.net</link>
	<description>Prawo IP &#38; IT</description>
	<lastBuildDate>Sun, 14 Aug 2011 23:09:01 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>C-392/97</title>
		<link>http://orzecznictwo.net/c-39297/</link>
		<comments>http://orzecznictwo.net/c-39297/#comments</comments>
		<pubDate>Thu, 16 Sep 1999 09:47:26 +0000</pubDate>
		<dc:creator>Tomasz Rychlicki</dc:creator>
				<category><![CDATA[Art. 3(a) Regulation 1768/92]]></category>
		<category><![CDATA[Art. 3(b) Regulation 1768/92]]></category>
		<category><![CDATA[Dodatkowe świadectwo ochronne]]></category>
		<category><![CDATA[Prawo UE]]></category>
		<category><![CDATA[Trybunał Sprawiedliwości WE]]></category>
		<category><![CDATA[Wpisy w języku angielskim]]></category>

		<guid isPermaLink="false">http://orzecznictwo.net/?p=144</guid>
		<description><![CDATA[Zagadnienia: Preliminary ruling in the proceedings of SPC. Wnioski: 1. On a proper construction of Council Regulation EEC No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products and, in particular, Article 3(b) thereof, where a product in the form referred to in the marketing authorisation is protected [...]]]></description>
			<content:encoded><![CDATA[<p><strong>Zagadnienia:</strong><br />
Preliminary ruling in the proceedings of SPC.</p>
<p><strong>Wnioski:</strong><br />
1. On a proper construction of Council Regulation EEC No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products and, in particular, Article 3(b) thereof, where a product in the form referred to in the marketing authorisation is protected by a basic patent in force, the supplementary protection certificate is capable of covering the product, as a medicinal product, in any of the forms enjoying the protection of the basic patent.</p>
<p>2. In order to determine, in connection with the application of Regulation No 1768/92 and, in particular, Article 3(a) thereof, whether a product is protected by a basic patent, reference must be made to the rules which govern that patent. </p>
<p><strong>Tekst wyroku:</strong><br />
<a href="http://www.curia.eu/jurisp/cgi-bin/gettext.pl?where=&#038;lang=pl&#038;num=80009083C19970392&#038;doc=T&#038;ouvert=T&#038;seance=ARRET">C-392/97</a>, Farmitalia Carlo Erba.</p>
<p><strong>Opublikowany:</strong><br />
&#8212;</p>
]]></content:encoded>
			<wfw:commentRss>http://orzecznictwo.net/c-39297/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

